Are Doctors Prepared for Direct-to-Consumer Advertising of Genetics Tests?  

Oleh:

Tracy, Erin E.

Jenis: Article from Journal - ilmiah internasional
Dalam koleksi: Obstetrics and Gynecology vol. 110 no. 06 (Dec. 2007), page 1389.

Ketersediaan

Perpustakaan FK Nomor Panggil: O01.K.2007.04 Non-tandon: 1 (dapat dipinjam: 0) Tandon: tidak ada

Lihat Detail Induk

Isi artikel

patients and physicians alike are now well familiar with the often emotional appeals for medications ever present in printed media and television. Dr. Hollon describes this as the $3.2-bilion-per-year uncontrolled experiment wuth direct-to-consumer advertising in the United States resulting from the food and Drug Administration's 1997 decision to relax the rules regarding pharmaceutical advertising. The amount of money spent on direct-to-consumer advertising of pharmaceuticals increased by 212% between 1996 and 2000. In 2000 drug companies spent 685 million dollars on advertisements in newspapaers and popular magazines, which significantly more than the $473 million spent for medical journal ads. The investment by pharmaceutical companies in advertising campaigns has not mirored by the efforts by the food and Drug Administration to regulate these practices. Although the amount spent by drug companies for promotions increased from $11 bilion in 1997 to $15.7 bilion in 2000, for example, there was a significant decrease in the number of letters of warning issued by the FDA to companies regarding advertising regulation violations during the same period ( from 139 letters in 1997 to 79 in 2000 ).

Opini Anda

Klik untuk menuliskan opini Anda tentang koleksi ini!

Kembali